Information on results of RFP - 026413 - LONG-TERM STABILITY STUDY OF DRUG PRODUCT IN cGMP STANDARD 

In connection with co-financing the project "Clinical trial of the first phase (Ia/Ib) of a fusion protein with a dual anticancer mechanism", financed from the State budget by Medical Research Agency (no. 2022/ABM/05/00006-00), acting pursuant to §8 of the co-financing agreement, Adamed Pharma S.A. informs that  the order will be awarded to:   

  • Biotechpharma UAB